{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-175514","form_type":"8-K","ticker":"GRTX","cik":"0001563577","company_name":"Galera Therapeutics, Inc.","filed_at":"2022-06-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.212926+00:00","generated_at":"2026-06-25T01:15:56.270192+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Galera Therapeutics stockholders elect two Class III directors, ratify KPMG as auditor","bullets":["Dr. Emmett Cunningham and Dr. J. Mel Sorensen elected as Class III directors with ~10.6M and ~10.7M votes for, respectively.","KPMG LLP ratified as independent auditor for FY2022 with 17,167,149 votes for, 46,053 against, and 9,939 abstained.","Approximately 64.21% of outstanding shares (17,223,141) were present or represented at the annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-175514","json":"https://secwatch.observer/filing/0001193125-22-175514.json","markdown":"https://secwatch.observer/filing/0001193125-22-175514.md","text":"https://secwatch.observer/filing/0001193125-22-175514.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1563577/000119312522175514/0001193125-22-175514-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1563577/000119312522175514/d315061d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T01:15:56.270192+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}